<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.4'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/eeuu-311-tiotropio-para-que-sirve/</loc>
  <lastmod>2026-11-07T16:19:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Tiotropio (Spiriva Respimat, HandiHaler): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-11-07T16:19:39Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/07/sacubitrilo-valsartan-insuficiencia-cardiaca-dosis-transicion-ieca-36-horas/</loc>
  <lastmod>2026-11-07T11:13:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Sacubitrilo/valsartán en insuficiencia cardíaca: dosis, ventana de 36 horas al cambiar de IECA y efectos adversos (ESC 2026)</news:title>
   <news:publication_date>2026-11-07T11:13:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/sindrome-condensacion-pulmonar/</loc>
  <lastmod>2026-11-06T22:14:40Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Síndrome de condensación pulmonar: signos y su LR</news:title>
   <news:publication_date>2026-11-06T22:11:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/mcm-citocinas-tnf-alfa-il6-insulina-dia-37/</loc>
  <lastmod>2026-11-06T19:34:30Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Citocinas proinflamatorias: TNF-alfa, IL-6 y resistencia a la insulina &amp;#124; Medicina Cardiometabólica · Día 37</news:title>
   <news:publication_date>2026-11-06T19:34:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/endo-prueba-tolerancia-insulina-dia-37/</loc>
  <lastmod>2026-11-06T19:56:48Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prueba de tolerancia a la insulina: eje corticotropo y somatotropo &amp;#124; Endocrinología · Día 37</news:title>
   <news:publication_date>2026-11-06T19:32:40Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/cardio-primer-ruido-cardiaco-intensidad-dia-37/</loc>
  <lastmod>2026-11-06T19:30:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Primer ruido cardiaco: origen y variaciones en su intensidad &amp;#124; Cardiología · Día 37</news:title>
   <news:publication_date>2026-11-06T19:30:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/mi-perfil-bioquimico-basico-dia-37/</loc>
  <lastmod>2026-11-06T19:56:35Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Perfil bioquímico básico: glucosa, urea, creatinina y electrolitos &amp;#124; Medicina Interna · Día 37</news:title>
   <news:publication_date>2026-11-06T19:28:53Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/eeuu-310-medicare-cubre-glp1-2027/</loc>
  <lastmod>2026-11-06T16:20:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>¿Cubre Medicare los medicamentos GLP-1 en 2027? Estado actual</news:title>
   <news:publication_date>2026-11-06T16:20:45Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/06/examen-fisico-dislipidemia-xantelasma-xantomas-tendinosos-arco-corneal/</loc>
  <lastmod>2026-11-06T11:15:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Examen físico de la dislipidemia: xantelasma, xantomas tendinosos y arco corneal, qué aportan y cuándo sospechar hipercolesterolemia familiar</news:title>
   <news:publication_date>2026-11-06T11:15:02Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/mcm-macrofagos-m1-m2-tejido-adiposo-dia-36/</loc>
  <lastmod>2026-11-05T22:39:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Macrófagos M1 y M2 en el tejido adiposo &amp;#124; Medicina Cardiometabólica · Día 36</news:title>
   <news:publication_date>2026-11-05T22:39:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/endo-estimulacion-acth-synacthen-dia-36/</loc>
  <lastmod>2026-11-05T22:36:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prueba de estimulación con ACTH sintética (Synacthen) &amp;#124; Endocrinología · Día 36</news:title>
   <news:publication_date>2026-11-05T22:36:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/cardio-signos-perifericos-insuficiencia-cardiaca-dia-36/</loc>
  <lastmod>2026-11-05T22:33:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Signos periféricos de insuficiencia cardiaca &amp;#124; Cardiología · Día 36</news:title>
   <news:publication_date>2026-11-05T22:33:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/mi-recuento-morfologia-plaquetaria-dia-36/</loc>
  <lastmod>2026-11-05T22:30:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Recuento y morfología plaquetaria en el hemograma &amp;#124; Medicina Interna · Día 36</news:title>
   <news:publication_date>2026-11-05T22:30:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/broncofonia-egofonia-pectoriloquia-afona/</loc>
  <lastmod>2026-11-05T22:11:26Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Egofonía, broncofonía y pectoriloquia áfona: su LR</news:title>
   <news:publication_date>2026-11-05T22:11:26Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/eeuu-309-retiro-atorvastatina-40-mg/</loc>
  <lastmod>2026-11-05T16:24:11Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Retiro de atorvastatina 40 mg: qué lotes afecta la FDA, qué hacer y precios (2026)</news:title>
   <news:publication_date>2026-11-05T16:24:11Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/05/riesgo-cardiometabolico-aha-2026-zeus-lpa-horizon-obesidad-hipertension/</loc>
  <lastmod>2026-11-05T11:13:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Riesgo cardiometabólico en AHA 2026: qué esperar de ZEUS, Lp(a)HORIZON y los ensayos de obesidad e hipertensión</news:title>
   <news:publication_date>2026-11-05T11:13:39Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
